Hiroyuki Mori — Endo Lab

article 2007

P1-IS-105 New strategy for medical treatment of endometriosis :

article 2006

P-355

·doi:10.1016/j.fertnstert.2006.07.711

article 2002

Effect of alendronate and menatetrenone administration on bone formation during Gn-RH agonist treatment for endometriosis

·doi:10.1016/s0015-0282(02)04098-0

article 2001

CA-125 dynamic test: a novel method for clinical diagnosis of endometriosis.

·doi:10.1016/s0015-0282(01)02435-9

article 2000

Effectiveness of long term GN‐RH agonist administration for treatment of endometriosis combined with estrogen‐progestogen add back therapy

·doi:10.1016/s0020-7292(00)82576-x

article 1999

Rates of Endometriosis Recurrence and Pregnancy 1 Year after Treatment with Intranasal Buserelin Acetate (Suprecur®) (A Prospective Study)

Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.1999.tb01141.x

OBJECTIVES: This multicenter prospective study of buserelin acetate (Suprecur) therapy for endometriosis was performed in order to examine pregnancy rates and the recurrence of endometriosis 1 year after the end of intranasal administration…

article 1998

Suppression of macrophage activation by peritoneal fluid from patients with endometriosis

FEMS immunology and medical microbiology ·doi:10.1111/j.1574-695x.1998.tb01133.x

To investigate the effects of peritoneal fluid from patients with endometriosis on mouse peritoneal macrophages (Mphi), peritoneal fluid from endometriosis patients (n = 15) were added to a monolayer of C3H/HeJ mouse peritoneal Mphi. Tumor …